Artificial Intelligence in Oncology

• Published in: Applied sciences 2024-12, Vol.15 (1), p.269
• Main Authors: Jeziorski, Krzysztof, Olszewski, Robert
• Format: Article
• Language: English
• ISSN: 2076-3417; 2076-3417
• DOI: 10.3390/app15010269

The aim of the article is to highlight the key role of artificial intelligence in modern oncology. The search for scientific publications was carried out through the following web search engines: PubMed, PMC, Web of Science, Scopus, Embase and Ebsco. Artificial intelligence plays a special role in oncology and is considered to be the future of oncology. The largest application of artificial intelligence in oncology is in diagnostics (more than 80%), particularly in radiology and pathology. This can help oncologists not only detect cancer at an early stage but also forecast the possible development of the disease by using predictive models. Artificial intelligence plays a special role in clinical trials. AI makes it possible to accelerate the discovery and development of new drugs, even if not necessarily successfully. This is done by detecting new molecules. Artificial intelligence enables patient recruitment by combining diverse demographic and medical patient data to match the requirements of a given research protocol. This can be done by reducing population heterogeneity, or by prognostic and predictive enrichment. The effectiveness of artificial intelligence in oncology depends on the continuous learning of the system based on large amounts of new data but the development of artificial intelligence also requires the resolution of some ethical and legal issues.